Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2022

Conditions
Cancer PainQuality of LifePain, AcuteCannabis Use
Interventions
DRUG

PPP001

1 cannabis dosing capsule inhaled 3 times a day with a vaporizer device

DRUG

Placebo

1 placebo dosing capsule inhaled 3 times a day with a vaporizer device

Trial Locations (1)

85331

RECRUITING

Scottsdale Research Institute, Cave Creek

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Tetra Bio-Pharma

INDUSTRY

NCT04042545 - Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter